E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: Analysis of 125 patients

Urology

Volumn 67, Issue 4, 2006, Pages 797-802

  Sousa Madeira Campos, Rodrigo ^a   Lopes, Ademar ^a   Cardoso Guimarães, Gustavo ^a   Lopes Carvalho, André ^a   Augusto Soares, Fernando ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GELATINASE A; GELATINASE B; UVOMORULIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CELL INFILTRATION; CELL VACUOLE; CLINICAL FEATURE; CONTROLLED STUDY; CORPUS CAVERNOSUM; CORRELATION ANALYSIS; DISEASE SEVERITY; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; KOILOCYTOSIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MALE; PENIS AMPUTATION; PENIS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RACE DIFFERENCE; RECURRENCE RISK; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; UNIVARIATE ANALYSIS; URETHRA CANCER; VEIN EMBOLISM; VENOUS CIRCULATION;

ADULT; AGED; CADHERINS; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; HUMANS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PENILE NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33645983631     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.10.026     Document Type: Article

References (24)

1. Brumini R. Câncer no Brasil: Dados Histopatológicos 1976-80: Resultados (1982), Campanha Nacional de Combate ao Câncer, Ministério da Saûde, Rio de Janeiro 118-119
2. Burgers J.K., Badalament R.A., and Drago J.R. Penile cancer. clinical presentation, diagnosis and staging. Urol Clin North Am 19 (1992) 247-256
3. Kamat M.R., Kulkarni J.N., and Tagaonkar H.B. Carcinoma of the penis. the Indian experience. J Surg Oncol 52 (1993) 50-55
4. Lopes A., Hidalgo G.S., Kowalski L.P., et al. Prognostic factors in carcinoma of the penis. multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 156 (1996) 1637-1642
5. Fraley E.E., Zhang G., Sazama R., et al. Cancer of the penis. prognosis and treatment plans. Cancer 55 (1985) 1618-1624
6. Lopes A., Bezerra A.L.R., Pinto C.A.L., et al. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma. analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol 168 (2002) 81-86
7. Behrens J., Marceel M.M., Van Roy F.M., et al. Dissecting tumor cell invasion. epithelial cells acquire invasive properties after the loss or uvomorulin-mediated cell-cell adhesion. J Cell Biol 108 (1989) 2435-2447
8. Umbas R., Schalken J.A., Alders T.W., et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52 (1992) 5104-5109
9. Inada S., Koto T., Futami K., et al. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor). Surg Today 29 (1999) 493-503
10. Rodrigo J.P., Dominguez F., Alvarez C., et al. Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. Eur J Cancer 38 (2002) 1059-1064
11. Eglebad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2 (2002) 161-174
12. Kusukawa J., Sasaguri Y., Shima I., et al. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. a clinical pathologic study. Anatomic Pathol 99 (1993) 18-23
13. Vihinen P., and Kähäri V.-M. Matrix metalloproteinases in cancer. prognostic markers and therapeutic targets-mini review. Int J Cancer 99 (2002) 157-166
14. International Union Against Cancer. TNM Classification of Malignant Tumours. Penis. 6th ed. (2002), International Union Against Cancer, Geneva
15. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
16. Cox D.R. Regression models and life-tables. J R Stat Soc 34 (1972) 187-220
17. Pomp J., Blom J., Van Krimpen C., et al. E-cadherin expression in oesophageal carcinoma treated with high-dose radiotherapy. correlation with pretreatment parameters and treatment outcome. J Cancer Res Clin Oncol 125 (1999) 641-645
18. Krecicki T., Zalesska-Krecicka M., Jelen M., et al. Expression of type IV collagen and matrix metalloproteinase-2 (type IV collagenase) in relation to nodal status in laryngeal cancer. Clin Otorinolaryngol 26 (2001) 469-472
19. Brummer O., Böhmer G., Hollwitz B., et al. MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation. an immunohistochemical study. Gynecol Oncol 84 (2002) 222-227
20. Friguglietti C.U., Mello E.S., Castro I.V., et al. Metalloproteinase-9 immunoexpression and angiogenesis in thyroid follicular neoplasms. relation to clinical and histopathologic features. Head Neck 22 (2000) 373-379
21. Zeng Z., Huang Y., Cohen A., et al. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 14 (1996) 3133-3140
22. Horenblas S., Van Tinteren H., Delemarre J.F.M., et al. Squamous cell carcinoma of the penis. accuracy of Tumor, Nodes and Metastasis classification system, and role of lymphangiography, computerized tomography scan and fine needle aspiration cytology. J Urol 146 (1991) 1279-1283
23. Dekernion J.B., Tynberg P., Persky L., et al. Carcinoma of the penis. Cancer 32 (1973) 1256-1262
24. Solsona E., Iborra I., Ricós J.V., et al. Corpus cavernosum invasion and tumor grade in the prediction of lymph node condition in penile carcinoma. Eur Urol 22 (1992) 115-118